|
| 37495798 | Early versus delayed coronary angiography in patients with out-of-hospital cardiac arrest and no ST-segment elevation: a systematic review and meta-analysis of randomized controlled trials. | Clin Res Cardiol | 2024 |
| 37771050 | Impact of stroke history on procedural cerebrovascular insult probability and long-term outcome after TAVI. | | 2024 |
| 34761886 | New ECG algorithms with improved accuracy for prediction of culprit vessel in inferior ST-segment elevation myocardial infarction. | Panminerva Medica | 2023 |
| 36099163 | Incidence, causes, correlates, and outcome of bioprosthetic valve dysfunction and failure following transcatheter aortic valve implantation. | European Heart Journal Cardiovascular Imaging | 2023 |
| 36217578 | Metabolomics implicate eicosanoids in severe functional mitral regurgitation. | ESC heart failure | 2023 |
| 36128956 | Permanent pacemaker implantation and left bundle branch block with self-expanding valves - a SCOPE 2 subanalysis. | EuroIntervention | 2023 |
| 35727948 | Elucidation of the genetic causes of bicuspid aortic valve disease. | Cardiovasc Res | 2023 |
| 37848174 | Treatment Satisfaction and Convenience for Patients With Atrial Fibrillation on Edoxaban or Vitamin K Antagonists After Transcatheter Aortic Valve Replacement: A Post Hoc Analysis from the ENVISAGE-TAVI AF Trial. | | 2023 |
| 37599395 | Reduction in Tc-DPD myocardial uptake with therapy of ATTR cardiomyopathy. | | 2023 |
| 37741105 | Predictors of All-Cause Mortality After Successful Transcatheter Aortic Valve Implantation in Patients With Atrial Fibrillation. | | 2023 |
| 37586346 | Patterns of Aortic Valve Replacement in Europe: Adoption by Age. | | 2023 |
| 37646165 | Proteomic Atlas of Atherosclerosis: The Contribution of Proteoglycans to Sex Differences, Plaque Phenotypes, and Outcomes. | | 2023 |
| 37638826 | Sex-Related Disparities in Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Type 2 Diabetes and Heart Failure. | | 2023 |
| 37629221 | Right Atrial Phasic Function in Heart Failure with Preserved Ejection Fraction: Cardiac Magnetic Resonance Feature Tracking and Outcomes. | | 2023 |
| 37870628 | Impact of right ventricular-to-pulmonary artery coupling on remodeling and outcome in patients undergoing transcatheter edge-to-edge mitral valve repair. | | 2023 |
| 37773184 | Effect of monovalent COVID-19 vaccines on viral interference between SARS-CoV-2 and several DNA viruses in patients with long-COVID syndrome. | | 2023 |
| 37549339 | Myocardial structural and functional changes in cardiac amyloidosis - Insights from a prospective observational patient registry. | | 2023 |
| 37861385 | Tricuspid edge-to-edge repair for tricuspid valve prolapse and flail leaflet. Feasibility in comparison to patients with secondary tricuspid regurgitation. | | 2023 |
| 36656688 | Soluble urokinase plasminogen activator receptor and survival in elective cardiac surgery. | | 2023 |
| 37210596 | Obesity in heart failure with preserved ejection fraction with and without diabetes: risk factor or innocent bystander? | | 2023 |
| 36963781 | Prescribing trends of sodium-glucose cotransporter 2 inhibitors in patients with heart failure with preserved, mildly reduced and reduced ejection fraction. | | 2023 |
| 36710528 | Monitoring of mitral- and tricuspid valve interventions with CardioMEMS: Insights beyond imaging. | | 2023 |
| 37462329 | Quantitative fluid overload in severe aortic stenosis refines cardiac damage and associates with worse outcomes. | | 2023 |
| 36757905 | A streamlined, machine learning-derived approach to risk-stratification in heart failure patients with secondary tricuspid regurgitation. | | 2023 |
| 37190856 | Short-term toll-like receptor 9 inhibition leads to left ventricular wall thinning after myocardial infarction. | | 2023 |
| 37062864 | Contemporary insights into the epidemiology, impact and treatment of secondary tricuspid regurgitation across the heart failure spectrum. | | 2023 |
| 36802737 | Relationship of Fibroblast Growth Factor 23 With Hospitalization for Heart Failure and Cardiovascular Outcomes in Patients Undergoing Cardiac Surgery. | | 2023 |
| 37373788 | The Impact of Preclinical High Potent P2Y Inhibitors on Decision Making at Discharge and Clinical Outcomes in Patients with Acute Coronary Syndrome. | | 2023 |
| 37240352 | Soluble ST2 in Patients with Carotid Artery Stenosis-Association with Plaque Morphology and Long-Term Outcome. | | 2023 |
| 36855009 | Detection of sympathetic denervation defects in Fabry disease by hybrid [C]meta-hydroxyephedrine positron emission tomography and cardiac magnetic resonance. | | 2023 |
| 36789997 | Cardiac amyloidosis: a significant blind spot of the H2FPEF score. | | 2023 |
| 37489732 | The Early neo2 Registry: Transcatheter Aortic Valve Implantation With ACURATE in a European Population. | | 2023 |
| 37036268 | Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO-3 randomized trial. | | 2023 |
| 35055405 | Transcatheter Versus Surgical Valve Repair in Patients with Severe Mitral Regurgitation. | Journal of Personalized Medicine | 2022 |
| 35909264 | Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial. | European Heart Journal | 2022 |
| 35593128 | Relationship of diabetes, heart failure, and N-terminal pro-B-type natriuretic peptide with cardiovascular outcomes in patients with atrial fibrillation. | ESC heart failure | 2022 |
| 35710734 | Prevalence and Outcomes of Cardiac Amyloidosis in All-Comer Referrals for Bone Scintigraphy. | | 2022 |
| 36040717 | Two-year clinical outcomes after successful transcatheter aortic valve implantation with balloon-expandable versus self-expanding valves: A subanalysis of the GALILEO trial. | Catheterization and Cardiovascular Interventions | 2022 |
| 35965066 | Edoxaban vs. Vitamin K Antagonist for Atrial Fibrillation After Transcatheter Aortic Valve Replacement in Japanese Patientsã¿¿- A Subanalysis of the ENVISAGE-TAVI AF Trial. | Circulation Journal | 2022 |
| 35450838 | Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2. | EuroIntervention | 2022 |
| 35583363 | 6-Month Outcomes of the TricValve System in Patients With Tricuspid Regurgitation: The TRICUS EURO Study. | JACC: Cardiovascular Interventions | 2022 |
| 36294424 | Core Lab Adjudication of the ACURATE <i>neo2</i> Hemodynamic Performance Using Computed-Tomography-Corrected Left Ventricular Outflow Tract Area. | J Clin Med | 2022 |
| 35893287 | Cardiogenic Shock Does Not Portend Poor Long-Term Survival in Patients Undergoing Primary Percutaneous Coronary Intervention. | Journal of Personalized Medicine | 2022 |
| 36008266 | Unveiling Cardiac Amyloidosis, its Characteristics, and Outcomes Among Patients With MR Undergoing Transcatheter Edge-to-Edge MV Repair. | JACC: Cardiovascular Interventions | 2022 |
| 35628989 | Comparison of Hepatic Tissue Characterization between T1-Mapping and Non-Contrast Computed Tomography. | Journal of Clinical Medicine | 2022 |
| 36337874 | Heart failure with preserved ejection fraction: Calculating the risk of future heart failure events and death. | Frontiers in Cardiovascular Medicine | 2022 |
| 35934563 | Outcomes After Transcatheter Aortic Valve Implantation in Men Versus Women. | American Journal of Cardiology | 2022 |
| 36063138 | Interleukin-4 receptor alpha signaling regulates monocyte homeostasis. | FASEB J | 2022 |
| 35926911 | The Complexity of Subtle Cardiac Tracer Uptake on Bone Scintigraphy. | JACC: Cardiovascular Imaging | 2022 |
| 35861981 | Reverse Remodeling Following Valve Replacement in Coexisting Aortic Stenosis and Transthyretin Cardiac Amyloidosis. | Circulation: Cardiovascular Imaging | 2022 |